164 related articles for article (PubMed ID: 26577699)
1. Fibulin-5 Blocks Microenvironmental ROS in Pancreatic Cancer.
Wang M; Topalovski M; Toombs JE; Wright CM; Moore ZR; Boothman DA; Yanagisawa H; Wang H; Witkiewicz A; Castrillon DH; Brekken RA
Cancer Res; 2015 Dec; 75(23):5058-69. PubMed ID: 26577699
[TBL] [Abstract][Full Text] [Related]
2. Hypoxia and Transforming Growth Factor β Cooperate to Induce Fibulin-5 Expression in Pancreatic Cancer.
Topalovski M; Hagopian M; Wang M; Brekken RA
J Biol Chem; 2016 Oct; 291(42):22244-22252. PubMed ID: 27531748
[TBL] [Abstract][Full Text] [Related]
3. Loss of fibulin-5 binding to beta1 integrins inhibits tumor growth by increasing the level of ROS.
Schluterman MK; Chapman SL; Korpanty G; Ozumi K; Fukai T; Yanagisawa H; Brekken RA
Dis Model Mech; 2010; 3(5-6):333-42. PubMed ID: 20197418
[TBL] [Abstract][Full Text] [Related]
4. Extracellular Matrix Induction of Intracellular Reactive Oxygen Species.
Huang H; Du W; Brekken RA
Antioxid Redox Signal; 2017 Oct; 27(12):774-784. PubMed ID: 28791881
[TBL] [Abstract][Full Text] [Related]
5. Persistent activation of pancreatic stellate cells creates a microenvironment favorable for the malignant behavior of pancreatic ductal adenocarcinoma.
Tang D; Wang D; Yuan Z; Xue X; Zhang Y; An Y; Chen J; Tu M; Lu Z; Wei J; Jiang K; Miao Y
Int J Cancer; 2013 Mar; 132(5):993-1003. PubMed ID: 22777597
[TBL] [Abstract][Full Text] [Related]
6. Microenvironmental factors and extracellular matrix degradation in pancreatic cancer.
Binker MG; Binker-Cosen MJ; Binker-Cosen AA; Cosen-Binker LI
JOP; 2014 Jul; 15(4):280-5. PubMed ID: 25076320
[TBL] [Abstract][Full Text] [Related]
7. Transferrin receptor regulates pancreatic cancer growth by modulating mitochondrial respiration and ROS generation.
Jeong SM; Hwang S; Seong RH
Biochem Biophys Res Commun; 2016 Mar; 471(3):373-9. PubMed ID: 26869514
[TBL] [Abstract][Full Text] [Related]
8. Matrix control of pancreatic cancer: New insights into fibronectin signaling.
Topalovski M; Brekken RA
Cancer Lett; 2016 Oct; 381(1):252-8. PubMed ID: 26742464
[TBL] [Abstract][Full Text] [Related]
9. Extracellular matrix stimulates reactive oxygen species production and increases pancreatic cancer cell survival through 5-lipoxygenase and NADPH oxidase.
Edderkaoui M; Hong P; Vaquero EC; Lee JK; Fischer L; Friess H; Buchler MW; Lerch MM; Pandol SJ; Gukovskaya AS
Am J Physiol Gastrointest Liver Physiol; 2005 Dec; 289(6):G1137-47. PubMed ID: 16037546
[TBL] [Abstract][Full Text] [Related]
10. PLAC8 Localizes to the Inner Plasma Membrane of Pancreatic Cancer Cells and Regulates Cell Growth and Disease Progression through Critical Cell-Cycle Regulatory Pathways.
Kaistha BP; Lorenz H; Schmidt H; Sipos B; Pawlak M; Gierke B; Kreider R; Lankat-Buttgereit B; Sauer M; Fiedler L; Krattenmacher A; Geisel B; Kraus JM; Frese KK; Kelkenberg S; Giese NA; Kestler HA; Gress TM; Buchholz M
Cancer Res; 2016 Jan; 76(1):96-107. PubMed ID: 26669866
[TBL] [Abstract][Full Text] [Related]
11. Design and discovery of novel quinazolinedione-based redox modulators as therapies for pancreatic cancer.
Pathania D; Sechi M; Palomba M; Sanna V; Berrettini F; Sias A; Taheri L; Neamati N
Biochim Biophys Acta; 2014 Jan; 1840(1):332-43. PubMed ID: 23954204
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of fibroblast growth factor receptor 4 in high-grade pancreatic intraepithelial neoplasia and pancreatic ductal adenocarcinoma.
Motoda N; Matsuda Y; Onda M; Ishiwata T; Uchida E; Naito Z
Int J Oncol; 2011 Jan; 38(1):133-43. PubMed ID: 21109934
[TBL] [Abstract][Full Text] [Related]
13. Cysteine depletion induces pancreatic tumor ferroptosis in mice.
Badgley MA; Kremer DM; Maurer HC; DelGiorno KE; Lee HJ; Purohit V; Sagalovskiy IR; Ma A; Kapilian J; Firl CEM; Decker AR; Sastra SA; Palermo CF; Andrade LR; Sajjakulnukit P; Zhang L; Tolstyka ZP; Hirschhorn T; Lamb C; Liu T; Gu W; Seeley ES; Stone E; Georgiou G; Manor U; Iuga A; Wahl GM; Stockwell BR; Lyssiotis CA; Olive KP
Science; 2020 Apr; 368(6486):85-89. PubMed ID: 32241947
[TBL] [Abstract][Full Text] [Related]
14. Reactive Oxygen Species and Targeted Therapy for Pancreatic Cancer.
Zhang L; Li J; Zong L; Chen X; Chen K; Jiang Z; Nan L; Li X; Li W; Shan T; Ma Q; Ma Z
Oxid Med Cell Longev; 2016; 2016():1616781. PubMed ID: 26881012
[TBL] [Abstract][Full Text] [Related]
15. Differential modulation of cellular phenotype and drug sensitivity by extracellular matrix proteins in primary and metastatic pancreatic cancer cells.
Usman OH; Kumar S; Walker RR; Xie G; Sumajit HC; Jalil AR; Ramakrishnan S; Dooling LJ; Wang YJ; Irianto J
Mol Biol Cell; 2023 Dec; 34(13):ar130. PubMed ID: 37903222
[TBL] [Abstract][Full Text] [Related]
16. Concurrent PEDF deficiency and Kras mutation induce invasive pancreatic cancer and adipose-rich stroma in mice.
Grippo PJ; Fitchev PS; Bentrem DJ; Melstrom LG; Dangi-Garimella S; Krantz SB; Heiferman MJ; Chung C; Adrian K; Cornwell ML; Flesche JB; Rao SM; Talamonti MS; Munshi HG; Crawford SE
Gut; 2012 Oct; 61(10):1454-64. PubMed ID: 22234980
[TBL] [Abstract][Full Text] [Related]
17. Overexpressed EDIL3 predicts poor prognosis and promotes anchorage-independent tumor growth in human pancreatic cancer.
Jiang SH; Wang Y; Yang JY; Li J; Feng MX; Wang YH; Yang XM; He P; Tian GA; Zhang XX; Li Q; Cao XY; Huo YM; Yang MW; Fu XL; Li J; Liu DJ; Dai M; Wen SY; Gu JR; Hong J; Hua R; Zhang ZG; Sun YW
Oncotarget; 2016 Jan; 7(4):4226-40. PubMed ID: 26735172
[TBL] [Abstract][Full Text] [Related]
18. Hypoxia activates the hedgehog signaling pathway in a ligand-independent manner by upregulation of Smo transcription in pancreatic cancer.
Onishi H; Kai M; Odate S; Iwasaki H; Morifuji Y; Ogino T; Morisaki T; Nakashima Y; Katano M
Cancer Sci; 2011 Jun; 102(6):1144-50. PubMed ID: 21338440
[TBL] [Abstract][Full Text] [Related]
19. Ribonucleoprotein HNRNPA2B1 interacts with and regulates oncogenic KRAS in pancreatic ductal adenocarcinoma cells.
Barceló C; Etchin J; Mansour MR; Sanda T; Ginesta MM; Sanchez-Arévalo Lobo VJ; Real FX; Capellà G; Estanyol JM; Jaumot M; Look AT; Agell N
Gastroenterology; 2014 Oct; 147(4):882-892.e8. PubMed ID: 24998203
[TBL] [Abstract][Full Text] [Related]
20. The anti-oxidative transcription factor Nuclear factor E2 related factor-2 (Nrf2) counteracts TGF-β1 mediated growth inhibition of pancreatic ductal epithelial cells -Nrf2 as determinant of pro-tumorigenic functions of TGF-β1.
Genrich G; Kruppa M; Lenk L; Helm O; Broich A; Freitag-Wolf S; Röcken C; Sipos B; Schäfer H; Sebens S
BMC Cancer; 2016 Feb; 16():155. PubMed ID: 26915435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
